高血壓症と腎機能(第3報) : 實驗的内分泌性高血壓並びに實驗的神經性高血壓症
スポンサーリンク
概要
- 論文の詳細を見る
EXPERIMENTAL ENDOCRINE HYPERTENSION Among the endocrine glands, adrenal glands are considered to play a most important role in hypertension. Since Goldblatt observed for the first time that bilateral adrenalectomy interfered with the development or maintenance of experimental renal hypertension, the role of the adrenal cortex in hypertension has been discussed. Experimentally, since it is difficult to produce hypertension in dogs by administration of adrenal cortical hormones (DCA ets.), it was in this study attempted to produce a persistent hypertension by ligation of the adrenal veins in dogs. It was the purpose of this study to examine whether a surgical procedure on the adrenal in the natural state can cause hypertension.In this study, 13 trained dogs were used for the operation, which was performed on one side of adrenal glands and after 1-2 weeks on the other side. Blood pressure was measured directly on the femoral artery by mercury manometer. Effective renal plasma flow, glomerular filtration rate and filtration fraction were determined by renal clearance technique. At the same time, plasma Na and urine Na were measured.In some cases blood pressure was elevated after ligation of adrenal veins in one side, while the added operation on the other side showed a depressor effect. In others, the operation on both sides produced slight sustained hypertension. At that time RPF increased (10-70 %), GFR increased (25-90 %) and FF was unchanged, but the reabsorption of sodium in kidneys increased in most hypertensive animals. The histochemical study of adrenal cortex revealed signs of hyperfunction in zona glomerulosa.According to these results, the increase in amount of sodium reabsorption due to hyperfunction of zona glomerulosa is considered to play a great role in the pathogensis of hypertension.In conclusion, the above-mentioned results suggest that the patterns of Cushing's syndrome as well as Addison's disease may be produced artificially. It is assumed that the adrenal cortex is intimately concerned with sodium metabolism, where the retention of Na would be a factor in the pathogenesis of endocrine hypertension.EXPERIMENTAL NEUROGENIC HYPERTENSION In the opinions of many investigators, the nervous system occupies the domainant place in maintaining the elevated blood pressure during the chronic stage of hypertension, and humoral agents merely initiate the rise during the first few weeks of hypertension. The term "neurogenic" is used broadly, but usually "neurogenic" suggests the sympathetic component of the autonomic nervous system.Here, the participation of neurogenic factor in hypertension and its mechanism were studied by the section of buffer nerves and by using ganglionic blocking agents and adrenolytic agents.In pressoreceptor deneving hypertension, I attempted to study the elevation of blood pressure in its relation to the RPF, renal vascular resistance and GFR, and to study its mechanism. In this study, 10 trained dogs were used. Among them, 1 showed slight, 2 moderate and 4 marked hypertension. Percentage of success was 70 %. If the cases with transient elevation of blood pressure were included in the group of success, the percentage of success was 100 %.The elevated blood pressure reached a peak within one week after operation. The blood pressure fluctuated, but bacame sustained during weeks, and then decreased gradually. In some cases, the elevated blood pressure continued for over one year.Renal plasma flow increased along with the development of hypertension in all animals (7-43 %, average 22 %), but was not parallel with blood pressure and so renal vascular resistance increased.In conclusion, the hypertension due to section of buffer nerves may belong to the pheochromocytoma type, and its initiating mechanism is probably secretion of adrenalin and/or nor-adrenalin. The renal plasma flow showed an increase, but a dynamic equilibrium may exist between renal ischemia in a wide sense and an elevation of blood pressure.Next, to clarify the neurogenic factor in hypertension, effects of ganglionic blocking agents and adrenolytic agents on blood pressure and on renal hemodynamics were studied. I used 1-hydrazinophthalazine, hexamethonium bitartarate and veratrum viride.1) 1-Hydrazinophthalazine : The subjects were 4 normal, 1 pressoreceptor denerved and 2 dogs with Goldblatt's procedure. Following intraveneus injection of 0.3-0.4 mg/kg, RPF increased and there were decreases in FF and renal vascular resistance. But following injection of 1-2 mg/kg, RPF decreased in most subjects unexpectedly, and GFR and urine flow decreased.2) Hexamethonium bitartarate : After injection of hexamethonium, renal plasma flow initially decreased paralleling to lowering of blood pressure, and then returned to control value despite more lowering of blood pressure.3) Veratrum viride : Effects of renal functions were similar to hexamethonium.
- 社団法人日本循環器学会の論文
- 1958-03-20
著者
関連論文
- 20) 高血壓症の臨床統計學的研究(第2報)(第4回日本循環器學會近畿地方學會總會)
- 心不全と食鹽に就ての臨床的研究
- 231)DCA及び食鹽高血壓(一般演説,第17回日本循環器學會總會)
- 92) 心腎機能と電解質代謝(續報)(第23回日本循環器學會總會)
- 15) 僧帽辧口狭窄の交連切開例 示説(第1回日本循環器學會近畿地方學會總會記事)
- 3) 高血壓症の臨床統計學的研究(第1報)(第2回日本循環器學會近畿地方學會總會)
- 高血壓症と腎機能(第1報) : 緒論並びに腎機能測定法 : 特に腎クリアランス法に依る腎血行力學的研究の方法
- 後天性心臟瓣膜疾患に於ける腎機能
- 6)Mgの測定とその代謝(第17回日本循環器学会近畿地方会)
- 59)心疾患における尿中電解質排泄の日内変動について : 講演会一般演題
- 126)循環器系と腎機能 : 實驗竝に臨床的方面(一般演説,第17回日本循環器學會總會)
- 37) ATPの臨床効果(第19回日本循環器學會總會)
- 高血壓症と腎機能(第7報) : 臨床的研究 : 本態性高血壓症及高血壓症とATP-ATPase系に關する臨床的觀察
- 高血壓症と腎機能(第6報) : 臨床的研究 : 神經性高血壓症
- 高血壓と腎機能(第5報) : 臨床的研究 : 腎性高血壓症及び内分泌性高血壓症
- 高血壓症と腎機能(第4報) : 腎 ATPase "MAEKAWA"靜脈内注入による實驗的高血壓症
- 高血壓症と腎機能(第3報) : 實驗的内分泌性高血壓並びに實驗的神經性高血壓症
- 高血壓症と腎機能(第2報) : 第三部 實驗的高血壓症